QSS
VRNA

Quantitative Systematic Strategies’s Verona Pharma VRNA Stock Holding History

Quantitative Systematic Strategies’s Portfolio VRNA Stock Details VRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-14,034
Closed -$92K – 362
2021
Q2 		$92K Sell
14,034
-15,136
-52% -$105K 0.03% 437
2021
Q1 		$244K Buy
+29,170
New +$242K 0.04% 514

Other funds holding VRNA

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

Quantitative Systematic Strategies's VRNA Position: Q3 2021 in Review

Quantitative Systematic Strategies sold out of Verona Pharma (VRNA) in Q3 2021, closing a stake of 14,034 shares — an estimated $92K sold.

Quantitative Systematic Strategies first reported a position in VRNA in Q1 2021 and held it in 2 quarters. The position peaked at $244K in Q1 2021. 40 funds tracked by Wall St. Rank hold VRNA as of Q3 2021.

  • Quantitative Systematic Strategies reported no remaining Verona Pharma position as of Q3 2021 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 14,034 Verona Pharma shares in Q3 2021, an estimated $92K.
  • Quantitative Systematic Strategies first reported a position in Verona Pharma in Q1 2021 and held it in 2 quarters.
  • Quantitative Systematic Strategies's Verona Pharma position peaked at $244K in Q1 2021.
  • 40 funds tracked by Wall St. Rank held Verona Pharma as of Q3 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q3 2021, filed 16 Nov 2021.